Sort
39,280 grants matching “leukemia”
Computational Tools For Bioinformatics And Genome Analysis
$1,004,300John I Powell · Center For Information Technology · ZIA · FY2014 · CT
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,004,229Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Metabolic basis of B cell lineage leukemia relapse
$1,003,965Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2019 · CA
Mechanistic and translational studies of CBF leukemia
$1,003,899Paul Liu · National Human Genome Research Institute · ZIA · FY2016 · HG
Adaptable and scalable electroporation for cellular therapy
$1,002,657Harold G Craighead · Cytequest, Inc. · R44 · FY2024 · GM
COGNITIVE REMEDIATION FOR CHILDHOOD CANCER SURVIVORS
$1,002,403Oregon Health And Science University · R01 · FY2000 · CA
Non-Clinical Pharmacology of CX-01
$1,002,340Galina Vid · Ceramedix Holding, Llc · R44 · FY2024 · AI
Metabolic basis of B cell lineage leukemia relapse
$1,002,111Markus Mãschen · Yale University · R35 · FY2021 · CA
SPORE in Lung Cancer
$1,002,096Bruce E. Johnson · Dana-Farber Cancer Inst · P20 · FY2007 · CA
Chromatin and epigenetic memory
$1,001,734Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Cancer and Leukemia Group B-Leukemia Correlative Science
$1,000,836Michael A Caligiuri · Ohio State University · U10 · FY2008 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,000,669Irving Lerner Weissman · Stanford University · R35 · FY2023 · CA
Spectral imaging for automated malignant blast counting
$1,000,582Cambridge Research And Instrumentation · R44 · FY2005 · CA
Measureable Residual Disease testing for acute myeloid leukemia with single-cell genotyping
$1,000,002David W Ruff · Mission Bio, Inc. · R44 · FY2019 · CA
AI-based AML risk stratification using next generation cytogenomics
$1,000,000Stephen Matthew Eacker · Phase Genomics, Inc. · R44 · FY2023 · CA
Comparative Approach to the Hematopoietic Stem Cell
$1,000,000Children'S Hospital Boston · U01 · FY2004 · DK
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer
$1,000,000Alexander Federation · Talus Bioscience, Inc. · R44 · FY2023 · CA
CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM
$1,000,000University Of California San Diego · P01 · FY2005 · CA
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
$1,000,000James Lee · Id4pharma, Llc · R44 · FY2018 · CA
Non-Activated Natural Killer Cell Engineering For Enhanced Cytotoxic Potential
$1,000,000Michael Chiu · Kytopen Corp · R44 · FY2025 · AI
SAC-COVID: An FDA-approved Phase III clinical trial evaluating the safety and therapeutic efficacy of CD24Fc in severe COVID-19 patients
$1,000,000Pan Zheng · Oncoimmune, Inc. · R44 · FY2020 · CA
Production Technology for Recombinant Intravenous Immunoglobulin
$1,000,000David Scott Johnson · Gigagen, Inc. · R44 · FY2019 · AI
Comparative Approach to the Hematopoietic Stem Cell
$1,000,000Children'S Hospital Boston · U01 · FY2003 · DK
A next-generation meningococcal serogroup B vaccine with improved effectiveness for all age groups
$1,000,000Gregory Robert Moe · Omvax, Inc. · R44 · FY2021 · AI
DCTD Cancer Diagnosis
$1,000,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA